IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.993
AS - Asia 19.449
EU - Europa 16.148
SA - Sud America 4.437
AF - Africa 526
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 22
Totale 71.625
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.525
SG - Singapore 7.130
RU - Federazione Russa 4.956
CN - Cina 4.818
IT - Italia 4.599
BR - Brasile 3.465
VN - Vietnam 2.576
GB - Regno Unito 1.776
HK - Hong Kong 1.402
BD - Bangladesh 1.306
DE - Germania 1.108
CA - Canada 950
FR - Francia 660
FI - Finlandia 537
UA - Ucraina 470
IE - Irlanda 455
IN - India 429
AR - Argentina 347
MX - Messico 328
SE - Svezia 315
TR - Turchia 287
NL - Olanda 285
PL - Polonia 251
ID - Indonesia 223
ZA - Sudafrica 195
ES - Italia 192
IQ - Iraq 181
EC - Ecuador 177
IL - Israele 171
JP - Giappone 171
PK - Pakistan 156
CO - Colombia 115
AT - Austria 108
VE - Venezuela 93
MA - Marocco 86
AE - Emirati Arabi Uniti 80
UZ - Uzbekistan 76
DK - Danimarca 72
LT - Lituania 66
PY - Paraguay 63
CL - Cile 60
SA - Arabia Saudita 54
EG - Egitto 53
MY - Malesia 50
TN - Tunisia 46
PE - Perù 45
KE - Kenya 44
CH - Svizzera 43
PH - Filippine 37
BE - Belgio 36
CR - Costa Rica 33
AU - Australia 32
UY - Uruguay 32
JO - Giordania 31
BO - Bolivia 30
AZ - Azerbaigian 29
DZ - Algeria 29
RO - Romania 25
CZ - Repubblica Ceca 23
JM - Giamaica 23
KZ - Kazakistan 22
NP - Nepal 22
DO - Repubblica Dominicana 21
HN - Honduras 19
OM - Oman 19
GT - Guatemala 18
EU - Europa 17
IR - Iran 17
AL - Albania 16
TH - Thailandia 16
TW - Taiwan 16
LB - Libano 15
PA - Panama 14
SK - Slovacchia (Repubblica Slovacca) 14
KR - Corea 13
NI - Nicaragua 13
PT - Portogallo 13
AM - Armenia 12
BG - Bulgaria 12
ET - Etiopia 12
GR - Grecia 12
KG - Kirghizistan 12
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
GE - Georgia 10
RS - Serbia 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
BB - Barbados 9
CI - Costa d'Avorio 9
HR - Croazia 9
HU - Ungheria 9
LV - Lettonia 9
SN - Senegal 9
BH - Bahrain 8
BY - Bielorussia 8
GY - Guiana 8
MC - Monaco 8
MD - Moldavia 8
NO - Norvegia 8
Totale 71.464
Salva come PNG Salva come JPEG
Città #
Dallas 6.244
Singapore 3.711
San Jose 2.303
Ashburn 2.251
Beijing 1.766
Chicago 1.471
Los Angeles 1.387
Hong Kong 1.324
Moscow 916
Ho Chi Minh City 837
Milan 775
New York 674
Salt Lake City 611
Chandler 562
Southend 543
Buffalo 529
Rome 516
Hanoi 502
The Dalles 469
Fairfield 462
San Mateo 451
Dublin 446
Santa Clara 435
Houston 411
Council Bluffs 377
Lauterbourg 360
Wilmington 360
São Paulo 359
Woodbridge 359
Hefei 354
Tampa 348
Helsinki 334
Cambridge 321
Seattle 315
Elk Grove Village 272
Boardman 257
Portsmouth 242
Falls Church 237
Munich 235
Pisa 225
Warsaw 217
Orem 215
Stevenage 215
Ann Arbor 212
Ottawa 210
Montreal 205
Beauharnois 193
Florence 190
Jacksonville 188
Brooklyn 173
Mexico City 166
London 164
Frankfurt am Main 158
Dearborn 156
Lawrence 155
Istanbul 151
Tel Aviv 148
Tokyo 146
Denver 142
Toronto 136
Sterling 133
Stockholm 130
Lancaster 129
Poplar 128
Chennai 126
Johannesburg 124
Amsterdam 123
Atlanta 122
Rio de Janeiro 118
Dong Ket 117
Phoenix 114
Nuremberg 113
Miami 111
Lappeenranta 107
Da Nang 105
Columbus 102
Figino 101
Bologna 100
Haiphong 98
Naples 98
Boston 95
Belo Horizonte 86
Dulles 79
Turin 79
Manchester 72
San Diego 72
Biên Hòa 70
Turku 70
Palermo 68
San Francisco 67
Washington 67
Tashkent 66
Genoa 65
Ankara 64
Mumbai 64
Charlotte 62
Brasília 61
Detroit 61
Quito 61
Guangzhou 60
Totale 41.779
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.843
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.703
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.576
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 890
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 729
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 615
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 487
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 450
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 436
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 431
A simple echocardiographic score to rule out cardiac amyloidosis 388
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 360
Building medical knowledge from real world registries: The case of heart failure 359
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 356
A simple echocardiographic score to rule out cardiac amyloidosis 354
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 341
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 330
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 330
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 325
Treating chemoreflex in heart failure: modulation or demolition? 324
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 320
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 314
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 311
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 307
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 306
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 304
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 300
Eligibility for vericiguat in a real‐world, contemporary heart failure population 298
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 298
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 297
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 295
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 292
[Ten perspectives for research and innovation in cardiac amyloidosis] 291
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 291
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 291
Screening the health status of people working in a university 290
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 286
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 285
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 284
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 282
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 282
How to take arms against central apneas in heart failure 281
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 281
Sex-related differences in chronic heart failure 280
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 278
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 269
Cardiac light-chain deposition disease relapsing in the transplanted heart 269
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 268
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 268
Unmet needs in end-of-life care for heart failure patients 265
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 265
Atrial amyloidosis: mechanisms and clinical manifestations 261
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 260
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 260
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 259
null 258
Valve disease in cardiac amyloidosis: an echocardiographic score 258
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 258
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 258
null 258
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 256
Biomarkers for the diagnosis and management of heart failure: New frontiers 256
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 256
RNA-targeting and gene editing therapies for transthyretin amyloidosis 255
Disease features and management of cardiomyopathies in women 254
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 253
null 253
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 247
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 246
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 243
Assessing cardiac mechanics through left ventricular haemodynamic forces 241
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 241
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 241
Biomarkers for the diagnosis and management of heart failure 241
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 240
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 239
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 238
Cardiac magnetic resonance in patients with muscular dystrophies 238
Role of Imaging in Cardiomyopathies 235
Valvular heart disease in patients with cardiac amyloidosis 235
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 235
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 235
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 234
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 231
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 231
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 231
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 230
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 230
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 229
Cardiovascular disease and COVID-19: les liaisons dangereuses 228
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 227
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 227
Cardiac troponins as biomarkers for cardiac disease 227
Perspectives in noninvasive imaging for chronic coronary syndromes 225
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 225
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 225
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 224
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 224
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 223
Totale 33.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 349.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 349.465
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021321 0 0 0 0 0 0 0 0 0 0 0 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/202642.330 2.194 6.182 4.866 5.533 4.011 2.661 4.125 1.997 2.695 2.804 2.770 2.492
Totale 72.098